Development and Validation of Multi-Residue Method for Drugs Analysis in Human Feces by Liquid Chromatography-Tandem Mass Spectrometry.
Gabriel Míguez-SuárezAlejandra Cardelle-CobasLaura Sinisterra-LoaizaBeatriz I VázquezAlberto CepedaCarolina NebotPublished in: Molecules (Basel, Switzerland) (2022)
The use of veterinary drugs in animal production is a common practice to secure animal and human health. However, residues of administrated drugs could be present in animal food products. Levels of drugs in food of animal origin are regulated within the European Union. In recent years, residues have been detected not only in food, but also in the environmental elements such as water or soil, meaning that humans are involuntarily exposed to these substances. This article presents a multiclass method for the analysis of various therapeutic groups of pharmaceuticals in human feces. Pharmaceuticals are extracted from feces with an acid extraction solvent, and after filtration the extract was analyzed by HPLC-MS/MS. A limit of detection of 10 ng/g was achieved for 9 pharmaceuticals, with linearity over 0.99 and repeatability and reproducibility lower than 20%. The method was satisfactorily applied in 25 feces samples of individuals that had declared not to be under medical treatment for the last two months. Results indicate the presence of six different compounds at concentration between 10 and 456 ng/g. This preliminary study showed the involuntary exposure of human gut microbiota to active substances such as pharmaceuticals.
Keyphrases
- human health
- ms ms
- liquid chromatography tandem mass spectrometry
- endothelial cells
- risk assessment
- simultaneous determination
- induced pluripotent stem cells
- healthcare
- climate change
- pluripotent stem cells
- oxidative stress
- solid phase extraction
- drug induced
- high performance liquid chromatography
- quality improvement
- ionic liquid
- palliative care
- combination therapy
- amino acid
- real time pcr
- smoking cessation
- loop mediated isothermal amplification